Maximal blockade of TxA2 without compromised PGI2 formation; a superior profile of the TxA2 receptor blocking drug GR32191 over aspirin.
作者信息
Lumley P, Keery R J, Wharton K A, White B P, Watts I S
机构信息
Department of Peripheral Pharmacology, Glaxo Group Research Ltd., Ware, Hertfordshire, U.K.
出版信息
Adv Prostaglandin Thromboxane Leukot Res. 1991;21B:603-6.
PMID:1825385
Abstract
摘要
相似文献
1
Maximal blockade of TxA2 without compromised PGI2 formation; a superior profile of the TxA2 receptor blocking drug GR32191 over aspirin.
Adv Prostaglandin Thromboxane Leukot Res. 1991;21B:603-6.
2
Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.血栓素（Tx）A2受体阻断与TxA2合酶抑制单独及联合应用：对人血小板抗聚集疗效的比较
Br J Pharmacol. 1991 Feb;102(2):497-505. doi: 10.1111/j.1476-5381.1991.tb12200.x.
3
Preliminary assessment of a novel thromboxane A2 receptor-blocking drug, GR32191, in healthy subjects.新型血栓素A2受体阻断药物GR32191在健康受试者中的初步评估。
Circulation. 1990 Jan;81(1 Suppl):I53-8; discussion I59-60.
4
Pathophysiological actions of thromboxane A2 and their pharmacological antagonism by thromboxane receptor blockade with GR32191.血栓素A2的病理生理作用及其通过GR32191阻断血栓素受体的药理学拮抗作用。
Circulation. 1990 Jan;81(1 Suppl):I42-52; discussion I59-60.
5
The inhibitory effect of GR32191, a thromboxane receptor blocking drug, on human platelet aggregation, adhesion and secretion.血栓素受体阻断药物GR32191对人血小板聚集、黏附和分泌的抑制作用。
Thromb Haemost. 1989 Jun 30;61(3):429-36.
6
On the mechanism of the prolonged action in man of GR32191, a thromboxane receptor antagonist.关于血栓素受体拮抗剂GR32191在人体中的长效作用机制。
Adv Prostaglandin Thromboxane Leukot Res. 1991;21A:351-4.
7
Evidence for a role in thrombus stabilization for thromboxane A2 in human platelet deposition on collagen.血栓素A2在人血小板于胶原蛋白上沉积过程中对血栓稳定作用的证据。
J Lab Clin Med. 1992 Jun;119(6):690-7.
8
9
Pharmacokinetic and pharmacodynamic profiles of vapiprost, a selective, long-lasting thromboxane receptor antagonist, after single and multiple oral administration to healthy volunteers.在健康志愿者单次及多次口服选择性长效血栓素受体拮抗剂瓦匹前列素后的药代动力学和药效学特征。
J Clin Pharmacol. 1991 Sep;31(9):815-22. doi: 10.1002/j.1552-4604.1991.tb01917.x.
引用本文的文献
1
ZD1542, a potent thromboxane A2 synthase inhibitor and receptor antagonist in vitro.ZD1542，一种在体外具有强效的血栓素A2合酶抑制剂和受体拮抗剂。
Br J Pharmacol. 1993 Dec;110(4):1600-6. doi: 10.1111/j.1476-5381.1993.tb14007.x.
Zotero 插件